ShambaviDRichardMD

Physician

Dr. Richard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
325 W 15th St
New York, NY 10011
Phone+1 212-604-6021

Fax+1 201-418-9118

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1997 - 1998
BronxCare Health SystemResidency, Internal Medicine, 1992 - 1995
Stanley Medical College SMCClass of 1988

PubMed

MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients.
Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter
Blood Advances. 2024-11-15
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.
Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff
Blood Cancer Discovery. 2024-11-01
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.
Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, Jinming Song, Carlos M Morán-Segura
Blood Cancer Journal. 2024-10-16

Abstracts/Posters

Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
Shambavi Richard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

CAR-T Destined for Earlier Lines of Therapy in Blood Cancers, Experts SayNovember 18th, 2022